Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,219 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 604
Recruiting: 314
Ph III recruiting: 30
Growth YoY: +35.1%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1–50 of 3,219 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00040352	Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma	recruiting	—	3,000	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT00068003	Harvesting Cells for Experimental Cancer Treatments	enrolling by invitation	—	7,000	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials